Patrycja Baranowska

Patrycja Baranowska

Auto-generated profile, based on publicly available information

Patrycja Baranowska

Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2024 in Biomedical Materials
Verified
Journal Article
Open access
ZIZuzanna Iwoń
Zuzanna Iwoń
EKEwelina Krogulec
Ewelina Krogulec
AKAleksandra Kierlańczyk
Aleksandra Kierlańczyk
PBPatrycja Baranowska
Patrycja Baranowska
IŁIwona Łopianiak
Iwona Łopianiak
EJElżbieta Jastrzębska
Elżbieta Jastrzębska
Currently, numerous studies are conducted using nanofibers as a scaffold for culture cardiac cells; however, there still needs to be more research evaluating the impact of the physicochemical properties of polymer nanofibers on the structure and function of cardiac cells. We have studied how poly(ϵ-caprolactone) and polyurethane nanofibrous mats with different physicochemical properties influence the viability, morphology, orientation, and maturation of cardiac cells. For this purpose, the cells taken from different species were used. They were rat ventricular cardiomyoblasts (H9c2), mouse atrial cardiomyocytes (CMs) (HL-1), and human ventricular CMs. Based on the results, it can be concluded that cardiac cells cultured on nanofibers exhibit greater maturity in terms of orientation, morphology, and gene expression levels compared to cells cultured on polystyrene plates. Additionally, the physicochemical properties of nanofibers affecting the functionality of cardiac cells from different species and different parts of the heart were evaluated. These studies can support research on understanding and explaining mechanisms leading to cellular maturity present in the heart and the selection of nanofibers that will effectively help the maturation of CMs.

17 July 2024 in Macromolecular Bioscience
Verified
Journal Article
Closed access
JKJan M. Kurzyna
Jan M. Kurzyna
RKRafał J. Kopiasz
Rafał J. Kopiasz
MPMartyna Paul
Martyna Paul
MFMagdalena Flont
Magdalena Flont
PBPatrycja Baranowska
Patrycja Baranowska
DJDominik Jańczewski
Dominik Jańczewski

27 February 2026 in Sensors
Verified
Journal Article
Open access
PDF file
MFMagdalena Flont
Magdalena Flont
AŻAgnieszka Żuchowska
Agnieszka Żuchowska
OTOliwia Tadko
Oliwia Tadko
JKJoanna Konopka
Joanna Konopka
PMPaulina Musolf
Paulina Musolf
EJElżbieta Jastrzębska
Elżbieta Jastrzębska
Epithelial ovarian cancer (EOC) is a highly lethal malignancy characterized by significant heterogeneity and poor prognosis due to late-stage diagnosis and chemotherapy resistance. Traditional two-dimensional (2D) models fail to replicate the complexity of the tumor microenvironment (TME), necessitating the development of advanced in vitro systems. Here, we present a novel microfluidic tumor-on-a-chip (ToC) system that accurately models key features of EOC, including heterogeneity and vascularization. The developed cellular model was evaluated for functionality. It was demonstrated that endothelial cells of blood vessels within a collagen matrix successfully migrated toward the cancerous tissue, while the multicellular and multilayered tumor construct secreted pro-angiogenic factors. Additionally, long-term culture conditions induced inflammatory responses, mimicking in vivo tumor progression. This innovative platform enables precise investigations into EOC biology, angiogenesis, and TME interactions. Furthermore, it holds significant potential for drug screening, assessing therapeutic efficacy, and advancing personalized oncology approaches.

16 September 2026 in The Analyst
Verified
Journal Article
Closed access
PBPatrycja Baranowska
Patrycja Baranowska
TLTrinh Lam
Trinh Lam
AHAmy E. Herr
Amy E. Herr
Deterministic combinatorial indexing through a vacuum-driven microfluidic system enables barcoding of 512 microwells and supports integrated on-chip generation of high-quality single-cell ATAC-seq libraries.

22 April 2026 in ACS Omega
Verified
Journal Article
Open access
PBPatrycja Baranowska
Patrycja Baranowska
BŁBartłomiej Łuszczuk
Bartłomiej Łuszczuk
DKDominik Kołodziejek
Dominik Kołodziejek
JTJakub, Waldemar Trzciński
Jakub, Waldemar Trzciński
WŚWeronika Świtlik
Weronika Świtlik
EJElżbieta JastrzęBska
Elżbieta JastrzęBska
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide, with a five year survival rate below 10%. The high mortality rate of PDAC is primarily due to its aggressive metastatic nature, late diagnosis, and resistance to available therapies. A strategic research direction that demands significantly more attention is the identification of novel tumor markers and the development of tools for rapid, noninvasive diagnosis of this type of cancer. Circulating tumor cells (CTCs) are a promising target for early cancer detection via liquid biopsy, but their clinical application in PDAC is limited due to their rarity and technical challenges in reliable isolation and analysis. CTCs are typically isolated based on physical properties (size, density, deformability, charge, shape, hydrodynamics) or antigenic markers using specific antibodies. Although numerous cancer-specific antibodies have been identified, a marker uniquely distinguishing PDAC has yet to be found. In this work, we present the latest results concerning the development of a microfluidic platform that enables effective immunomagnetic isolation of PDAC cells from a complex biological sample using two potential PDAC markers: Plectin-1 and EpCAM. Here, we developed a low-cost, easy-to-manufacture, and user-friendly 3D-printed microfluidic platform that integrates a micromixer and a separation chamber for rapid cell isolation. Optimization tests showed that Plectin-1 at a concentration of 0.485 μg/mL captured 102 cells/ml with a recovery of 80% ± 13.3%, EpCAM at a concentration of 0.625 μg/mL captured 103 cells/ml with a recovery of 47% ± 13.3%, and the mixture of EpCAM and Plectin-1 at concentrations of 0.3125 μg/mL and 0.242 μg/mL, respectively, achieved a recovery of 91.3% ± 4.4%. To demonstrate the applicability of the method in biological samples, blood with different anticoagulants was tested. The highest detection sensitivity was achieved in the blood sample with citrate: Plectin-1 at 0.485 μg/mL enabled detection at a concentration of 102 cells/ml (47 ± 9% recovery), and EpCAM at 1.25 μg/mL achieved a 92 ± 8% recovery. The entire isolation process from biological samples was performed in less than 1 min. Using this system combined with antibody-functionalized magnetic nanoparticles targeting EpCAM and Plectin-1, we demonstrated the efficient capture of PDAC cells from biological samples, highlighting Plectin-1 as a promising PDAC marker and the potential of immunomagnetic microfluidic separation for improved diagnostics.

30 October 2025 in bioRxiv
Verified
Preprint
Open access
PBPatrycja Baranowska
Patrycja Baranowska
TLTrinh Lam
Trinh Lam
AHAmy E. Herr
Amy E. Herr
Achieving high throughput in experiments requiring sample indexing depends primarily on precise and reproducible reagent deposition prior to analysis. Contemporary droplet and microwell systems utilize random deposition of oligonucleotide-coated beads into reaction chambers, requiring costly bead synthesis and offering limited control over the final distribution of barcoded beads. As an alternative, we present deterministic, aqueous barcoding of 512 arrayed microwells using a multi-layer, vacuum-driven microfluidic network. To uniquely barcode each of the 512 microwells, we deposit DNA oligonucleotide solutions designed using a Combinatorial Dual Indexing (CDI) (i5, i7) scheme via deterministic loading. Deterministic fluid loading is achieved by sequentially mating two bifurcated, orthogonal microchannel networks to a planar microwell array. The microchannel networks actuate fluid flow through a combination of an applied vacuum force and a dead-end channel design. After loading the oligonucleotide solutions, we observed uniform barcode patterning across the arrays of microwells (∼20% CV), reasonable barcode loading times (30 - 40 min per step), and reduced reagent use (∼ 8-16 µL at 25 µM oligos vs. 10-50 µL at 100 µM for bead systems). We detected cross-contamination in ∼4% of the microwells. Following DNA barcode delivery, on-chip PCR of nuclear DNA from a breast-cancer cell line having the characteristics of the differentiated mammary epithelium (MCF7) was successfully performed, and off-chip quality control of the amplified breast cancer DNA was completed. Overall, we describe a deterministic and bead-free DNA barcoding strategy for efficient barcoding of microwell arrays that are important in single-cell analyses.